Braskem Pref ADR
BAK
Braskem Pref ADR (BAK) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.15
- EPS estimate
- −$0.60
- EPS surprise
- +74.53%
- Revenue surprise
- −3.99%
- Revenue
- $3.2B
- Revenue estimate
- $3.3B
- Reported
- Aug 7, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 7, 2025 | −$0.60 | −$0.15 | +74.53% | $3.2B | SEC |
| Q1 2025 | May 12, 2025 | $0.48 | $0.31 | −34.03% | $3.5B | SEC |
| Q4 2024 | Feb 27, 2025 | −$0.88 | −$2.50 | −184.24% | $3.3B | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.17 | −$0.25 | −50.66% | $3.7B | SEC |
| Q2 2024 | Aug 8, 2024 | −$1.04 | −$1.67 | −60.03% | $3.4B | SEC |
| Q1 2024 | May 9, 2024 | −$0.48 | −$0.62 | −28.75% | $3.5B | SEC |
| Q4 2023 | Mar 19, 2024 | −$0.34 | −$0.77 | −123.78% | $3.4B | SEC |
| Q3 2023 | Oct 27, 2023 | −$0.48 | −$1.23 | −157.77% | $3.4B | SEC |
| Q2 2023 | Aug 9, 2023 | −$0.31 | −$0.40 | −29.86% | $3.6B | SEC |
| Q1 2023 | May 9, 2023 | −$0.13 | $0.09 | +169.90% | $3.9B | SEC |
| Q4 2022 | Mar 23, 2023 | −$0.47 | −$0.86 | −84.71% | $3.8B | SEC |
| Q3 2022 | Nov 9, 2022 | $0.20 | −$0.67 | −435.94% | $4.8B | — |
| Q2 2022 | Invalid Date | $0.72 | −$0.69 | −194.90% | $4.9B | — |
| Q1 2022 | May 12, 2022 | $1.63 | $1.91 | +17.23% | $5.2B | — |
| Q4 2021 | Mar 17, 2022 | $1.79 | $0.27 | −84.84% | $5.6B | — |
| Q3 2021 | Invalid Date | $2.17 | $1.61 | −25.76% | $5.2B | — |
| Q2 2021 | Aug 5, 2021 | $2.97 | $3.63 | +22.32% | $5.1B | — |
| Q1 2021 | Invalid Date | $1.05 | $1.19 | +14.05% | $4.3B | — |
| Q3 2020 | Nov 12, 2020 | −$0.18 | −$0.66 | −263.25% | $3.0B | — |
| Q2 2020 | Aug 6, 2020 | −$0.79 | −$1.08 | −36.35% | $2.1B | — |
Quarterly revenue
Frequently asked questions
When did Braskem Pref ADR (BAK) last report earnings?
Braskem Pref ADR last reported on Aug 7, 2025, covering fiscal Q2 2025.
Did BAK beat earnings estimates?
Yes. Braskem Pref ADR reported EPS of −$0.15 for Q2 2025 against a −$0.60 estimate — a 74.53% beat.
How much revenue did BAK report last quarter?
Braskem Pref ADR reported $3.2B in revenue for Q2 2025, against a consensus estimate of $3.3B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.